Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic
Multisystem inflammatory syndrome in children (MIS-C) is a complex syndrome characterized by multi-organ involvement that has emerged in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. The clinical presentation of MIS-C is similar to Kawasaki disease but predominantly presents with fever and gastrointestinal symptoms, and severe cases can involve toxic shock and cardiac dysfunction. Epidemiological findings indicate that the majority of MIS-C patients test positive for SARS-CoV-2 antibodies. The pathogenesis and pathophysiology of MIS-C remain unclear, though immune dysregulation following SARS-CoV-2 infection is considered a major contributing factor. Current treatment approaches for MIS-C primarily involve intravenous immunoglobulin therapy and symptomatic supportive care. This review article provides a comprehensive overview of the definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prognosis of MIS-C.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics - 26(2024), 1 vom: 15. Jan., Seite 98-102 |
Sprache: |
Chinesisch |
---|
Weiterer Titel: |
新型冠状病毒感染流行背景下的儿童多系统炎症综合征 |
---|
Beteiligte Personen: |
Zhou, Bin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Child |
---|
Anmerkungen: |
Date Completed 26.01.2024 Date Revised 28.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.7499/j.issn.1008-8830.2306093 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367598930 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367598930 | ||
003 | DE-627 | ||
005 | 20240128232102.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240125s2024 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.7499/j.issn.1008-8830.2306093 |2 doi | |
028 | 5 | 2 | |a pubmed24n1273.xml |
035 | |a (DE-627)NLM367598930 | ||
035 | |a (NLM)38269467 | ||
035 | |a (PII)1008-8830(2024)01-0098-05 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Zhou, Bin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic |
246 | 3 | 3 | |a 新型冠状病毒感染流行背景下的儿童多系统炎症综合征 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.01.2024 | ||
500 | |a Date Revised 28.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Multisystem inflammatory syndrome in children (MIS-C) is a complex syndrome characterized by multi-organ involvement that has emerged in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. The clinical presentation of MIS-C is similar to Kawasaki disease but predominantly presents with fever and gastrointestinal symptoms, and severe cases can involve toxic shock and cardiac dysfunction. Epidemiological findings indicate that the majority of MIS-C patients test positive for SARS-CoV-2 antibodies. The pathogenesis and pathophysiology of MIS-C remain unclear, though immune dysregulation following SARS-CoV-2 infection is considered a major contributing factor. Current treatment approaches for MIS-C primarily involve intravenous immunoglobulin therapy and symptomatic supportive care. This review article provides a comprehensive overview of the definition, epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and prognosis of MIS-C | ||
650 | 4 | |a Review | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Child | |
650 | 4 | |a Coronavirus disease 2019 | |
650 | 4 | |a Multisystem inflammatory syndrome in children | |
650 | 4 | |a Severe acute respiratory syndrome coronavirus 2 | |
700 | 1 | |a Huang, Yu-Kun |e verfasserin |4 aut | |
700 | 1 | |a Hong, Shao-Xian |e verfasserin |4 aut | |
700 | 1 | |a Jiao, Fu-Yong |e verfasserin |4 aut | |
700 | 1 | |a Xie, Kai-Sheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics |d 2006 |g 26(2024), 1 vom: 15. Jan., Seite 98-102 |w (DE-627)NLM161132898 |x 1008-8830 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2024 |g number:1 |g day:15 |g month:01 |g pages:98-102 |
856 | 4 | 0 | |u http://dx.doi.org/10.7499/j.issn.1008-8830.2306093 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2024 |e 1 |b 15 |c 01 |h 98-102 |